- Home
- TIC vs GPCR Comparison
TIC vs GPCR Comparison
Compare TIC & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIC
- GPCR
- Stock Information
- Founded
- TIC 1991
- GPCR 2016
- Country
- TIC United States
- GPCR United States
- Employees
- TIC N/A
- GPCR N/A
- Industry
- TIC
- GPCR
- Sector
- TIC
- GPCR
- Exchange
- TIC Nasdaq
- GPCR Nasdaq
- Market Cap
- TIC 1.3B
- GPCR 1.1B
- IPO Year
- TIC N/A
- GPCR 2023
- Fundamental
- Price
- TIC $10.52
- GPCR $19.61
- Analyst Decision
- TIC Hold
- GPCR Strong Buy
- Analyst Count
- TIC 1
- GPCR 9
- Target Price
- TIC $11.00
- GPCR $75.63
- AVG Volume (30 Days)
- TIC 3.2M
- GPCR 898.3K
- Earning Date
- TIC 08-14-2025
- GPCR 08-06-2025
- Dividend Yield
- TIC N/A
- GPCR N/A
- EPS Growth
- TIC N/A
- GPCR N/A
- EPS
- TIC N/A
- GPCR N/A
- Revenue
- TIC $1,113,179,000.00
- GPCR N/A
- Revenue This Year
- TIC $5.80
- GPCR N/A
- Revenue Next Year
- TIC $5.77
- GPCR N/A
- P/E Ratio
- TIC N/A
- GPCR N/A
- Revenue Growth
- TIC 4.23
- GPCR N/A
- 52 Week Low
- TIC $8.76
- GPCR $13.22
- 52 Week High
- TIC $14.28
- GPCR $45.37
- Technical
- Relative Strength Index (RSI)
- TIC N/A
- GPCR 56.57
- Support Level
- TIC N/A
- GPCR $18.39
- Resistance Level
- TIC N/A
- GPCR $21.44
- Average True Range (ATR)
- TIC 0.00
- GPCR 1.18
- MACD
- TIC 0.00
- GPCR 0.31
- Stochastic Oscillator
- TIC 0.00
- GPCR 67.60
About TIC Acuren Corporation Common Stock
Acuren Corp operates as a provider of critical asset integrity services. The company provides testing, inspection, engineering and lab testing services in different industrial markets such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company's service line includes Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, etc., Rope Access Technician Solutions (RAT), and Engineering and Lab Testing. The company has two operating and reportable segments, which are the United States, generating maximum revenue, and Canada.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.